Table:
begin	end	state
1	62	cytoplasmic
63	82	transmembrane
83	101	non-cytoplasmic
102	122	transmembrane
123	128	cytoplasmic
129	149	transmembrane
150	155	non-cytoplasmic
156	179	transmembrane
180	197	cytoplasmic
198	217	transmembrane
218	229	non-cytoplasmic
230	250	transmembrane
251	281	cytoplasmic
282	305	transmembrane
306	316	non-cytoplasmic
317	334	transmembrane
335	345	cytoplasmic
346	364	transmembrane
365	369	non-cytoplasmic
370	391	transmembrane
392	402	cytoplasmic
403	423	transmembrane
424	428	non-cytoplasmic
429	448	transmembrane
449	460	cytoplasmic

Input:
>Pf6N2E2_1003 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_1003
MFEVDVAKHSCRGWHPALAQDLNMAWRALMTVNTKIKVPVMNTNTKALSGLTHNHEKLSS
TRLAFIFVTSLFFMWGLSHGLLDVLNKHFQDTLHISRGQSGLVQTAYFGAYFIIALPVGL
FMERFGYKAGILAGLALFAIGALLFIPASMVGTFMPFLVALFVLACGLGCLETAANLYAA
ALGDPAKSEQRLTFAQSFNGLGAFIGPVIGGAVFFAPPIEFNGNRVDLVSVTYAALAIIV
MLMFVAFARIQLPEIRNEKSSDVLLPSAGEVSLWKKSNFTGALVAQFCNVGAYVGIGAFF
INYAIDHWQGISAQKASYLLSLGMLAYMVGRFAGTWVMRYVPARSLLILNSLVSMVLCIV
AIAGFERISIFAVAAIYLFMSVMYPTIFAMGIRGLGTQTKKAGSCLVMTLVGGAFVPLLM
GALADHFGIAAAFYVPLACFAAIAWYGLSQPPVTASIKAH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server